Space Force unveils new themes for weapon systems to boost identity
The U.S. Space Force released names of space weapon systems to better link guardians with the force’s specific culture and...
The Clear Media Project
US admiral overseeing military operations in Latin America retires
DORAL, Fla. — A U.S. Navy admiral who oversees military operations in Latin America handed off command responsibilities Friday as...
GAO: Services aren’t sharing information on longtime Osprey problems
The Defense Department should improve information sharing among different services and offices to improve the V-22 Osprey tiltrotor aircraft’s safety...
Preschool network Head Start sues feds over ‘word ban’ of DEI terms
Head Start, an early-childhood network that pairs classroom learning with health and family support systems for infants through preschoolers at...
V-22 Osprey at risk of more ‘catastrophic’ mishaps, Navy review finds
On the heels of 12 major mishaps in the last four years, the military’s first tiltrotor aircraft program must take...
Lawmakers move to further restrict cellphones in DOD schools
Students in some Department of Defense schools will see more restrictions on using their cellphones or other portable electronic devices...
FDA to put most serious warning on COVID-19 vaccines: Report
The Food and Drug Administration intends to add a “black box” warning to COVID-19 vaccines in the Trump administration’s latest...
Pentagon to assess US munitions readiness; Trump accuses NYT of ‘seditious’ reporting about his health
In this Media Miss Minute, the Pentagon could soon be tasked with making sure the nation's munitions stockpiles are ready...
Eli Lilly touts strong results of new experimental weight loss drug retatrutide
Move over Ozempic, Wegovy, Mounjaro and Zepbound — Eli Lilly says another contender may be on the way. The pharmaceutical...
Trump weighs order to reclassify marijuana as a Schedule III drug
President Donald Trump is considering an executive order directing agencies to reclassify marijuana as a Schedule III drug, according to...
